Table 2.
Clinical data and mast cell signature gene expression data of 10 patients with lung adenocarcinoma from Borstel, Germany.52.
| Normalized expression of mast cell signature genes in lung adenocarcinoma compared with adjacent normal-appearing lung tissue (fold control genes GUSB/HPRT) |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| # | Gender | Age (years) | Grade (1–3) | T | N | M | TNM | control | common | cKIT- | cKIT+ |
| 1 | F | 61 | 3 | 3 | 1 | 0 | IIIa | 1,44 | 0,89 | 0,99 | 2,12 |
| 2 | M | 69 | 3 | 3 | 3 | 0 | IIIb | 1,11 | 0,79 | 1,22 | 1,77 |
| 3 | F | 66 | 3 | 3 | 0 | 0 | IIb | 0,82 | 0,55 | 1,28 | 6,59 |
| 4 | F | 58 | 3 | 2 | 2 | 1 | IV | 1,77 | 0,90 | 0,92 | 2,02 |
| 5 | F | 71 | 3 | 4 | 2 | 0 | IIIb | 1,23 | 0,92 | 1,10 | 3,05 |
| 6 | M | 74 | 3 | 3 | 2 | 0 | IIIa | 0,72 | 0,71 | 1,21 | 4,67 |
| 7 | F | 54 | 3 | 4 | 3 | 0 | IIIb | 1,19 | 1,53 | 0,72 | 4,81 |
| 8 | F | 53 | 3 | 3 | 0 | 0 | IIb | 0,69 | 2,06 | 0,80 | 3,48 |
| 9 | F | 74 | 2 | 2 | 2 | 0 | IIIa | 1,20 | 1,43 | 1,31 | 2,68 |
| 10 | F | 57 | 2–3 | 1 | 0 | 0 | Ia | 1,13 | 1,97 | 1,25 | 4,12 |